SCOTT MARBERRY: Open Payments
NPI 1972914174 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 24 payments from 10 companies in 2025. Trend: 2023 $1,029 · 2024 $1,242 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $281 |
| Lilly USA, LLC | 4 | $91 |
| Alnylam Pharmaceuticals Inc. | 3 | $75 |
| Amgen Inc. | 4 | $63 |
| Exact Sciences Corporation | 2 | $43 |
| ABBVIE INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| PFIZER INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Wegovy, GIVLAARI, OTEZLA, MOUNJARO, CAPLYTA, The Cologuard Plus Collection Kit, ELIQUIS, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
